Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karolien Walgraeve

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Drugs & Aging|February 17, 2022
Correction to: SGLT2 Inhibitors in Older Adults with Heart Failure with Preserved Ejection FractionJulie Hias, Laura Hellemans, Karolien Walgraeve, et al.
Drugs & Aging|February 4, 2022
SGLT2 Inhibitors in Older Adults with Heart Failure with Preserved Ejection FractionJulie Hias, Laura Hellemans, Karolien Walgraeve, et al.
Acta Clinica Belgica|June 11, 2019
Physician's feedback on a clinical pharmacy program on geriatric wardsJulie Hias, Karolien Walgraeve, Jos Tournoy, et al.
Drugs & Aging|April 20, 2018
Clinical Pharmacy Services on Geriatric Care Wards: Catch 22 of Implementation and ResearchLorenz Van der Linden, Julie Hias, Karolien Walgraeve, et al.
European Geriatric Medicine|October 16, 2021
Feasibility of optimizing pharmacotherapy in heart failure patients admitted to an acute geriatric ward: role of the clinical pharmacistKarolien Walgraeve, Lorenz Van der Linden, Johan Flamaing, et al.
Drugs & Aging|January 11, 2020
Clinical Pharmacy Services in Older Inpatients: An Evidence-Based ReviewLorenz Van der Linden, Julie Hias, Karolien Walgraeve, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 29, 2019
Medication review in older adults: Importance of time to benefitLorenz Van der Linden, Julie Hias, Isabel Spriet, et al.
Drugs & Aging|November 20, 2022
Estimating the Time to Benefit for Therapies in Heart Failure with Reduced Ejection Fraction: A Case Study of Sacubitril-Valsartan Using Reconstructed Data from a Randomized Controlled TrialLorenz Van der Linden, Julie Hias, Karolien Walgraeve, et al.
International Journal of Clinical Pharmacy|August 18, 2020
Deprescribing in geriatric inpatients is associated with a lower readmission risk: a case control studyLaura Hellemans, Julie Hias, Karolien Walgraeve, et al.
Acta Clinica Belgica|October 24, 2019
Factors associated with the number of clinical pharmacy recommendations: findings from an observational study in geriatric inpatientsLorenz Van Der Linden, Julie Hias, Karolien Walgraeve, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Drugs & Aging|February 17, 2022
Correction to: SGLT2 Inhibitors in Older Adults with Heart Failure with Preserved Ejection FractionJulie Hias, Laura Hellemans, Karolien Walgraeve, et al.
Drugs & Aging|February 4, 2022
SGLT2 Inhibitors in Older Adults with Heart Failure with Preserved Ejection FractionJulie Hias, Laura Hellemans, Karolien Walgraeve, et al.
Acta Clinica Belgica|June 11, 2019
Physician's feedback on a clinical pharmacy program on geriatric wardsJulie Hias, Karolien Walgraeve, Jos Tournoy, et al.
Drugs & Aging|April 20, 2018
Clinical Pharmacy Services on Geriatric Care Wards: Catch 22 of Implementation and ResearchLorenz Van der Linden, Julie Hias, Karolien Walgraeve, et al.
European Geriatric Medicine|October 16, 2021
Feasibility of optimizing pharmacotherapy in heart failure patients admitted to an acute geriatric ward: role of the clinical pharmacistKarolien Walgraeve, Lorenz Van der Linden, Johan Flamaing, et al.
Drugs & Aging|January 11, 2020
Clinical Pharmacy Services in Older Inpatients: An Evidence-Based ReviewLorenz Van der Linden, Julie Hias, Karolien Walgraeve, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 29, 2019
Medication review in older adults: Importance of time to benefitLorenz Van der Linden, Julie Hias, Isabel Spriet, et al.
Drugs & Aging|November 20, 2022
Estimating the Time to Benefit for Therapies in Heart Failure with Reduced Ejection Fraction: A Case Study of Sacubitril-Valsartan Using Reconstructed Data from a Randomized Controlled TrialLorenz Van der Linden, Julie Hias, Karolien Walgraeve, et al.
International Journal of Clinical Pharmacy|August 18, 2020
Deprescribing in geriatric inpatients is associated with a lower readmission risk: a case control studyLaura Hellemans, Julie Hias, Karolien Walgraeve, et al.
Acta Clinica Belgica|October 24, 2019
Factors associated with the number of clinical pharmacy recommendations: findings from an observational study in geriatric inpatientsLorenz Van Der Linden, Julie Hias, Karolien Walgraeve, et al.
Pageof 3